Papers - Sugimoto, Yoshikazu

非小細胞肺癌患者における免疫染色法を用いたBreast Cancer-Resistance Proteinの発現とGefitinibの治療効果.

'及川武史, 大平達夫, 臼田実男, 菅泰博, 中嶋英治, 西條天基, 坪井正博, 平野隆, 杉本芳一, 加藤治文*.'

東京医科大学雑誌 66(2)   66(2) 2008.04

Research paper (conference, symposium, etc.), Joint Work, Accepted

FOXO transcription factor-dependent p15INK4b and p19INK4d expression.

'Katayama K, Nakamura A, Sugimoto Y, Tsuruo T, Fujita N*.'

Oncogene 27 ( 12 ) 1677-1686 2008.03

Research paper (scientific journal), Joint Work, Accepted

癌化学療法におけるABCタンパク質-ABCB1とABCG2-.

杉本芳一.

最新医学 (/最新医学社)  62(11)   2528-2533 2007.11

Research paper (scientific journal), Single Work, Accepted

Breast cancer resistance protein (BCRP) affected acquired resistance to gefitinib in a “never-smoked female patient with advanced non-small cell lung cancer."

Usuda J, Ohira T, Suga Y, Oikawa Ichinose S, Maehara S, Ohtani K, Kajiwara N, Tsutsui H, Tsuboi M, Hirano Furukawa K, Okunaka T, Sugimoto Y, Kato H*.

Lung Cancer 58(2)   296-299 2007.11

Research paper (conference, symposium, etc.), Joint Work, Accepted

Flavonoids inhibit breast cancer resistance protein-mediated drug resistance: transporter specificity and structure-activity relationship.

'Katayama K, Masuyama K, Yoshioka S, Hasegawa H, Mitsuhashi J, Sugimoto Y*.'

Cancer Chemotherpy and Pharmacology 60(6)   789-797 2007.11

Research paper (scientific journal), Joint Work, Accepted

Retroviral integration site analysis and the fate of transduced clones in an MDR1 gene therapy protocol targeting metastatic breast cancer.

'Mitsuhashi J, Tsukahara S, Suzuki R, Oh-hara Y, Nishi S, Hosoyama H, Katayama K, Noguchi K, Minowa S, Shibata H, Ito Y, Hatake K, Aiba K, Takahashi S, Sugimoto Y*.'

Human Gene Therapy 18 ( 10 ) 895-906 2007.10

Research paper (scientific journal), Joint Work, Accepted

Pilot study of MDR1 gene transfer into hematopoietic stem cells and chemoprotection in metastatic breast cancer patients.

'Takahashi S, Aiba K, Ito Y, Hatake K, Nakane M, Kobayashi T, Minowa S, Shibata H, Mitsuhashi J, Tsukahara S, Ishikawa E, Suzuki R, Tsuruo T, Sugimoto Y*.'

Cancer Science 98(10)   1609-1616 2007.10

Research paper (scientific journal), Joint Work, Accepted

Inhibition of the mitogen-activated protein kinase pathway results in the down-regulation of P-glycoprotein.

'Katayama K, Yoshioka S, Tsukahara S, Mitsuhashi J, Sugimoto Y*.'

Molecular Cancer Therapeutics 6   2092-2102 2007.07

Research paper (scientific journal), Joint Work, Accepted

The identification of two germ-line mutations in the human breast cancer resistance protein gene that result in the expression of a low/non-functional protein.

'Yoshioka S, Katayama K, Okawa C, Takahashi S, Tsukahara S, Mitsuhashi J, Sugimoto Y*.'

Pharmaceutical Research 24   1108-1117 2007.06

Research paper (scientific journal), Joint Work, Accepted

新しい戦略による抗がん剤のスクリーニングのための委員会報告 ー制がん候補物質のスクリーニング成績・第11報ー.

'矢守隆夫*, 安藤俊夫, 上原至雅, 小野眞弓, 河野通明, 済木育夫, 内藤幹彦, 早川洋一, 鶴尾隆, 吉田稔, 杉本芳一, 馬島哲夫.'

癌と化学療法 34　supplement I   34 supplement I 2007.03

Research paper (scientific journal), Joint Work, Accepted

Estrogen-mediated posttranscriptional downregulation of P-glycoprotein in MDR1-transduced human breast cancer cells.

'Mutoh K, Tsukahara S, Mitsuhashi J, Katayama K, Sugimoto Y*.'

Cancer Science 97   1198-1204 2006.11

Research paper (scientific journal), Joint Work, Accepted

A T3587G Germline Mutation of the MDR1 Gene Encodes a Non-functional P-glycoprotein.

'Mutoh K, Mitsuhashi J, Kimura Y, Tsukahara S, Ishikawa E, Sai K, Ozawa S, Sawada J, Ueda K, Katayama K, Sugimoto Y*.'

Molecular Cancer Therapeutics 5   877-884 2006.04

Research paper (scientific journal), Joint Work, Accepted

薬学生の病院研修・臨床研究・症例検討における個人情報保護法への対応.

杉本芳一.

日本医療薬学会会報 (/日本医療薬学会)  10   16-21 2006.03

Research paper (scientific journal), Single Work, Accepted

Functional SNPs of BCRP in drug effect and inhibitor development.

'Yanase K, Tsukahara S, Mitsuhash J, Sugimoto Y*.'

Cancer Letters (/Elsevier)  234   73-80 2006.03

Research paper (scientific journal), Joint Work, Accepted

Modification of pyrimidine derivatives from antiviral agents to antitumor agents.

'Kimura H, Katoh T, Kajimoto T, Node M*, Hisaki M, Sugimoto Y, Majima T, Uehara Y, Yamori T.'

Anticancer Research 26   91-97 2006.02

Research paper (scientific journal), Joint Work, Accepted

Role of Cys-603 in dimer/oligomer formation of the breast cancer resistance protein (BCRP/ABCG2).

'Kage K, Fujita T, Sugimoto Y*.'

Cancer Science 96   866-872 2005.12

Research paper (scientific journal), Joint Work, Accepted

P53-defective tumors with a functional apoptosome-mediated pathway: a new therapeutic target.

'Mashima T, Oh-hara T, Sato S, Mochizuki M, Sugimoto Y, Yamazaki K, Hamada J, Tada M, Moriuchi T, Ishikawa Y, Kato Y, Tomoda H, Yamori T, Tsuruo T*.'

Journal of the National Cancer Institute 97   765-777 2005.05

Research paper (scientific journal), Joint Work, Accepted

Estrogen-mediated post-transcriptional down-regulation of breast cancer resistance protein/ABCG2.

'Imai Y, Ishikawa E, Asada S, Sugimoto Y*.'

Cancer Research 65   596-604 2005.01

Research paper (scientific journal), Joint Work, Accepted

Antimitotic activity and reversal of breast cancer resistance protein-mediated drug resistance by stilbenoids from Bletilla striata.

'Morita H, Koyama K, Sugimoto Y, Kobayashi J*.'

Bioorganic & Medicinal Chemistry Letters 15   1051-1054 2005.01

Research paper (scientific journal), Joint Work, Accepted

Gefitinib reverses breast cancer resistance protein-mediated drug resistance.

'Yanase K, Tsukahara S, Asada S, Ishikawa E, Imai Y, Sugimoto Y*.'

Molecular Cancer Therapeutics 3   1119-1125 2004.09

Research paper (scientific journal), Single Work, Accepted